The comprehensive study examined data from 11,765 patients across 280 cancer clinics, spanning diagnoses between January 2011 ...
Controversy exists over the optimum treatment for potentially resectable esophageal cancer because existing ... of cisplatin and fluorouracil (5-FU) with a paclitaxel-based regimen.